IGF-I stimulates reactive oxygen species (ROS) production and inhibits insulin-dependent glucose uptake via ROS in 3T3-L1 adipocytes

Growth Hormone and IGF Research

Volumn 20, Issue 3, 2010, Pages 212-219

  Fukuoka, Hidenori ^a   Iida, Keiji ^a   Nishizawa, Hitoshi ^a   Imanaka, Mari ^a   Takeno, Ryoko ^a   Iguchi, Genzo ^a   Takahashi, Michiko ^a   Okimura, Yasuhiko ^b   Kaji, Hidesuke ^c   Chihara, Kazuo ^a   Takahashi, Yutaka ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF HYOGO   (Japan)

Author keywords

3T3 L1 adipocyte; Adipocytes; IGF I; Insulin resistance; IRS 1; ROS

Indexed keywords

ACETYLCYSTEINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SOMATOMEDIN C;

ACROMEGALY; ADIPOCYTE; ARTICLE; ATTENUATION; CELL STRAIN 3T3; CONTROLLED STUDY; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INSULIN DEPENDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MICE; NADPH OXIDASE; OXIDATIVE STRESS; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES;

EID: 77953082421     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2010.02.001     Document Type: Article

References (41)

1. Kuzuya H., Matsuura N., Sakamoto M., Makino H., Sakamoto Y., Kadowaki T., Suzuki Y., Kobayashi M., Akazawa Y., Nomura M., et al. Trial of insulin like growth factor i therapy for patients with extreme insulin resistance syndromes. Diabetes 1993, 42:696-705.
2. McDonald A., Williams R.M., Regan F.M., Semple R.K., Dunger D.B. Igf-i treatment of insulin resistance. Eur. J. Endocrinol. 2007, 157(Suppl. 1):S51-S56.
3. Moses A.C., Young S.C., Morrow L.A., O'Brien M., Clemmons D.R. Recombinant human insulin-like growth factor i increases insulin sensitivity and improves glycemic control in type ii diabetes. Diabetes 1996, 45:91-100.
4. Guler H.P., Zapf J., Froesch E.R. Short-term metabolic effects of recombinant human insulin-like growth factor i in healthy adults. N. Engl. J. Med. 1987, 317:137-140.
5. Melmed S., Ho K., Klibanski A., Reichlin S., Thorner M. Clinical review 75: recent advances in pathogenesis, diagnosis, and management of acromegaly. J. Clin. Endocrinol. Metab. 1995, 80:3395-3402.
6. Kasayama S., Otsuki M., Takagi M., H Saito, S Sumitani, H Kouhara, M Koga, Y Saitoh, T Ohnishi, Arita N. Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients. Clin. Endocrinol. (Oxf.) 2000, 52:549-555.
7. Colao A., Ferone D., Marzullo P., Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr. Rev. 2004, 25:102-152.
8. Mur C., Valverde A.M., Kahn C.R., Benito M. Increased insulin sensitivity in igf-i receptor - deficient brown adipocytes. Diabetes 2002, 51:743-754.
9. Flores-Riveros J.R., McLenithan J.C., Ezaki O., Lane M.D. Insulin down-regulates expression of the insulin-responsive glucose transporter (glut4) gene: effects on transcription and mRNA turnover. Proc. Natl. Acad. Sci. USA 1993, 90:512-516.
10. Bae Y.S., Kang S.W., Seo M.S., Baines I.C., Tekle E., Chock P.B., Rhee S.G. Epidermal growth factor (egf)-induced generation of hydrogen peroxide. Role in egf receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 1997, 272:217-221.
11. Bae Y.S., Sung J.Y., Kim O.S., Kim Y.J., Hur K.C., Kazlauskas A., Rhee S.G. Platelet-derived growth factor-induced h(2)o(2) production requires the activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 2000, 275:10527-10531.
12. Junn E., Lee K.N., Ju H.R., Han S.H., Im J.Y., Kang H.S., Lee T.H., Bae Y.S., Ha K.S., Lee Z.W., Rhee S.G., Choi I. Requirement of hydrogen peroxide generation in tgf-beta 1 signal transduction in human lung fibroblast cells: involvement of hydrogen peroxide and ca2+ in tgf-beta 1-induced il-6 expression. J. Immunol. 2000, 165:2190-2197.
13. Rhee S.G., Bae Y.S., Lee S.R., Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci. STKE 2000, 2000:PE1.
14. Mahadev K., Zilbering A., Zhu L., Goldstein B.J. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J. Biol. Chem. 2001, 276:21938-21942.
15. Mahadev K., Wu X., Zilbering A., Zhu L., Lawrence J.T., Goldstein B.J. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3t3-l1 adipocytes. J. Biol. Chem. 2001, 276:48662-48669.
16. Meng D., Shi X., Jiang B.H., Fang J. Insulin-like growth factor-i (igf-i) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species. Free Radic. Biol. Med. 2007, 42:1651-1660.
17. Iida K., Takahashi Y., Kaji H., Yoshioka S., Murata M., Iguchi G., Okimura Y., Chihara K. Diverse regulation of full-length and truncated growth hormone receptor expression in 3t3-l1 adipocytes. Mol. Cell. Endocrinol. 2003, 210:21-29.
18. Oliveira H.R., Verlengia R., Carvalho C.R., Britto L.R., Curi R., Carpinelli A.R. Pancreatic beta-cells express phagocyte-like nad(p)h oxidase. Diabetes 2003, 52:1457-1463.
19. Alblas J., Honing H., de Lavalette C.R., Brown M.H., Dijkstra C.D., van den Berg T.K. Signal regulatory protein alpha ligation induces macrophage nitric oxide production through jak/stat- and phosphatidylinositol 3-kinase/rac1/napdh oxidase/h2o2-dependent pathways. Mol. Cell. Biol. 2005, 25:7181-7192.
20. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004, 114:1752-1761.
21. Salvatorelli E., Guarnieri S., Menna P., Liberi G., Calafiore A.M., Mariggio M.A., Mordente A., Gianni L., Minotti G. Defective one- or two-electron reduction of the anticancer anthracycline epirubicin in human heart. Relative importance of vesicular sequestration and impaired efficiency of electron addition. J. Biol. Chem. 2006, 281:10990-11001.
22. Lin Y., Berg A.H., Iyengar P., Lam T.K., Giacca A., Combs T.P., Rajala M.W., Du X., Rollman B., Li W., Hawkins M., Barzilai N., Rhodes C.J., Fantus I.G., Brownlee M., Scherer P.E. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J. Biol. Chem. 2005, 280:4617-4626.
23. Mohanty J.G., Jaffe J.S., Schulman E.S., Raible D.G. A highly sensitive fluorescent micro-assay of h2o2 release from activated human leukocytes using a dihydroxyphenoxazine derivative. J. Immunol. Methods 1997, 202:133-141.
24. Tamori Y., Kawanishi M., Niki T., Shinoda H., Araki S., Okazawa H., Kasuga M. Inhibition of insulin-induced glut4 translocation by munc18c through interaction with syntaxin4 in 3t3-l1 adipocytes. J. Biol. Chem. 1998, 273:19740-19746.
25. Takahashi M., Takahashi Y., Takahashi K., Zolotaryov F.N., Hong K.S., Iida K., Okimura Y., Kaji H., Chihara K. Cxcl14 enhances insulin-dependent glucose uptake in adipocytes and is related to high-fat diet-induced obesity. Biochem. Biophys. Res. Commun. 2007, 364:1037-1042.
26. Takahashi Y., Shirono H., Arisaka O., Takahashi K., Yagi T., Koga J., Kaji H., Okimura Y., Abe H., Tanaka T., Chihara K. Biologically inactive growth hormone caused by an amino acid substitution. J. Clin. Invest. 1997, 100:1159-1165.
27. Herschkovitz A., Liu Y.F., Ilan E., Ronen D., Boura-Halfon S., Zick Y. Common inhibitory serine sites phosphorylated by irs-1 kinases, triggered by insulin and inducers of insulin resistance. J. Biol. Chem. 2007, 282:18018-18027.
28. Imoto K., Kukidome D., Nishikawa T., Matsuhisa T., Sonoda K., Fujisawa K., Yano M., Motoshima H., Taguchi T., Tsuruzoe K., Matsumura T., Ichijo H., Araki E. Impact of mitochondrial reactive oxygen species and apoptosis signal-regulating kinase 1 on insulin signaling. Diabetes 2006, 55:1197-1204.
29. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
30. del Rincon J.P., Iida K., Gaylinn B.D., McCurdy C.E., Leitner J.W., Barbour L.A., Kopchick J.J., Friedman J.E., Draznin B., Thorner M.O. Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes 2007, 56:1638-1646.
31. Clemmons D.R. Modifying igf1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat. Rev. Drug Discov. 2007, 6:821-833.
32. Fernandez A.M., Kim J.K., Yakar S., Dupont J., Hernandez-Sanchez C., Castle A.L., Filmore J., Shulman G.I., Le Roith D. Functional inactivation of the igf-i and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev. 2001, 15:1926-1934.
33. Steele-Perkins G., Turner J., Edman J.C., Hari J., Pierce S.B., Stover C., Rutter W.J., Roth R.A. Expression and characterization of a functional human insulin-like growth factor i receptor. J. Biol. Chem. 1988, 263:11486-11492.
34. Holzenberger M., Dupont J., Ducos B., Leneuve P., Geloen A., Even P.C., Cervera P., Le Bouc Y. Igf-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003, 421:182-187.
35. Migliaccio E., Giorgio M., Mele S., Pelicci G., Reboldi P., Pandolfi P.P., Lanfrancone L., Pelicci P.G. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999, 402:309-313.
36. Nemoto S., Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 2002, 295:2450-2452.
37. Migliaccio E., Giorgio M., Pelicci P.G. Apoptosis and aging: role of p66shc redox protein. Antioxid. Redox. Signal. 2006, 8:600-608.
38. Bluher M., Kahn B.B., Kahn C.R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003, 299:572-574.
39. Holdaway I.M., Rajasoorya R.C., Gamble G.D. Factors influencing mortality in acromegaly. J. Clin. Endocrinol. Metab. 2004, 89:667-674.
40. Biermasz N.R., Dekker F.W., Pereira A.M., van Thiel S.W., Schutte P.J., van Dulken H., Romijn J.A., Roelfsema F. Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor i measurements. J. Clin. Endocrinol. Metab. 2004, 89:2789-2796.
41. Nguyen M.T., Satoh H., Favelyukis S., Babendure J.L., Imamura T., Sbodio J.I., Zalevsky J., Dahiyat B.I., Chi N.W., Olefsky J.M. Jnk and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3t3-l1 adipocytes. J. Biol. Chem. 2005, 280:35361-35371.